gallbladder disease and semaglutide Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, disease, dehydration-related acute kidney injury GLP-1 receptor agonists and gallbladder

Many patients can successfully control reflux symptoms without discontinuing their weight loss medication by implementing these strategies

Weight loss injections, including glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound), have become increasingly popular for chronic weight management

Suboxone has also been shown to cause low cholesterol

Whole grains, fruits, nuts, and seeds are also excellent fiber sources

[8] Dehydration from gastrointestinal side effects such as nausea, vomiting, or diarrhoea can temporarily affect kidney function markers